Kiniksa Pharmaceuticals International
KNSA | NASDAQ
$78.56
+$0.43 (+0.55%)
Sep 22, 2026, 1:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 243.6M | 214.27M | 202.13M | 180.86M | 156.8M | 137.79M | 122.54M | 112.21M | 108.63M | 79.86M | 83.4M | 67.05M | 71.47M | 48.35M | 61.88M | 99.14M | 26.97M | 32.19M | 18.75M | 12.1M | 7.7M | n/a |
Cost of Revenue | 23.57M | 96.37M | 91.1M | 83.59M | 71.02M | 61.66M | 66.17M | 49.42M | 42.46M | 31.54M | 26.76M | 27.4M | 22.75M | 16.45M | 14.23M | 12.51M | 9.8M | 13.57M | 3.87M | 3.84M | 3.48M | 883K |
Gross Profit | 220.03M | 117.89M | 111.03M | 97.26M | 85.76M | 76.13M | 56.36M | 62.8M | 66.18M | 48.32M | 56.64M | 39.65M | 48.73M | 31.89M | 47.65M | 86.63M | 17.18M | 18.62M | 14.88M | 8.25M | 4.22M | -883K |
Operating Income | 27.19M | 29.27M | 19.77M | 24.02M | 20.16M | 13.27M | -19.3M | -9.66M | -117K | -16.54M | 81K | -10.93M | -3.15M | -11.2M | 6.05M | 46.41M | -19.37M | -23.32M | -36.13M | -30.67M | -40.56M | -49.28M |
Interest Income | 3.95M | 3.41M | 2.72M | 3.14M | 2.72M | 2.29M | 2.32M | 2.46M | 2.42M | n/a | 2.37M | 2.43M | 1.92M | 3.66M | 794K | 322K | 103K | 34K | 77K | 5K | 6K | 9K |
Pretax Income | 31.15M | 32.68M | 23.27M | 27.16M | 22.88M | 15.57M | -16.98M | -7.2M | 2.3M | -14.28M | 2.45M | -8.5M | -1.24M | -9.36M | 6.84M | 46.74M | -19.27M | -23.29M | -36.05M | -30.66M | -40.55M | -49.27M |
Net Income | 25.43M | 22.59M | 14.2M | 18.44M | 17.83M | 8.54M | -8.89M | -12.69M | -3.91M | -17.7M | 25.24M | -13.86M | 14.97M | -12.27M | 4.46M | 224.09M | -19.98M | -25.21M | -36.33M | -30.54M | -41.56M | -49.48M |
Selling & General & Admin | 63.87M | 61.15M | 56.78M | 49.1M | 46.86M | 43.53M | 40.54M | 46.4M | 42.4M | 38.68M | 36.74M | 33.76M | 28.41M | 28.2M | 27.22M | 23.91M | 23.1M | 21.48M | 22.74M | 20.06M | 21.25M | 20.01M |
Research & Development | 40.9M | 27.48M | 34.64M | 24.14M | 18.75M | 19.33M | 35.13M | 26.06M | 23.9M | 26.18M | 19.82M | 16.81M | 23.48M | 14.88M | 14.39M | 16.31M | 13.45M | 20.46M | 27.43M | 18.86M | 23.53M | 28.39M |
Other Expenses | 88.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 835K | n/a | n/a | n/a |
Operating Expenses | 192.83M | 88.63M | 91.26M | 73.24M | 65.62M | 62.86M | 75.66M | 72.46M | 66.29M | 64.86M | 56.56M | 50.58M | 51.88M | 43.09M | 41.61M | 40.21M | 36.54M | 41.94M | 51.01M | 38.92M | 44.78M | 48.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 216.41M | 185M | 182.36M | 156.83M | 136.64M | 124.51M | 141.84M | 121.87M | 108.75M | 96.4M | 83.31M | 77.97M | 74.63M | 59.54M | 55.84M | 52.72M | 46.34M | 55.51M | 54.88M | 42.76M | 48.26M | 49.28M |
Income Tax Expense | 5.71M | 10.09M | 9.07M | 8.72M | 5.05M | 7.03M | -8.09M | 5.49M | 6.21M | 3.43M | -22.79M | 5.36M | -16.21M | 2.91M | 2.38M | -177.36M | 716K | 1.93M | 279K | -118K | 1.01M | 210K |
Shares Outstanding (Basic) | 77.58M | 76.52M | 74.2M | 73.61M | 73.44M | 72.65M | 72.32M | 71.73M | 71M | 70.63M | 70.37M | 70.19M | 69.92M | 69.75M | 69.61M | 69.45M | 68.9M | 69.14M | 68.97M | 68.66M | 68.14M | 68.27M |
Shares Outstanding (Diluted) | 83.4M | 82.41M | 78.98M | 78.03M | 77.94M | 76.15M | 72.32M | 71.73M | 71M | 70.63M | 72.66M | 70.19M | 71.63M | 69.75M | 71.37M | 70.55M | 69.29M | 69.14M | 68.97M | 68.66M | 68.4M | 68.27M |
EPS (Basic) | 0.33 | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.20 | 0.21 | -0.18 | 0.06 | 3.23 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 |
EPS (Diluted) | 0.30 | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 | -0.12 | -0.18 | -0.06 | -0.25 | 0.35 | -0.20 | 0.21 | -0.18 | 0.06 | 3.18 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 |
EBITDA | 27.67M | 33.15M | 23.74M | 27.54M | 23.24M | 15.91M | -16.58M | -6.8M | 2.73M | -13.81M | 2.69M | -7.5M | -178K | -8.23M | 7.92M | 47.68M | -18.17M | -22.19M | -35.39M | -29.59M | -39.53M | -48.39M |
EBIT | 27.19M | 32.68M | 23.27M | 27.16M | 22.88M | 15.57M | -16.98M | -7.2M | 2.3M | -14.28M | 2.45M | -8.5M | -1.24M | -9.36M | 6.84M | 46.74M | -19.27M | -23.29M | -36.05M | -30.66M | -40.55M | -49.27M |
Depreciation & Amortization | 472K | 468K | 467K | 384K | 358K | 345K | 400K | 399K | 430K | 466K | 236K | 999K | 1.06M | 1.13M | 1.08M | 949K | 1.1M | 1.09M | 668K | 1.08M | 1.02M | 883K |
Add to Watchlist
Select watchlists to add or remove KNSA